Labstat Inc., A Certified Group Company, Highlights Need for Enhanced Cannabis Regulations to Protect Consumers
TORONTO — As Canada approaches the 5th anniversary of cannabis legalization, Labstat Inc., a leader in tobacco/nicotine, cannabis, hemp and NHP laboratory testing and research & development, underscores the need for more robust regulations and increased research funding to continue leading the way for the international community in this area. This call comes as Health Canada’s Expert Advisory Group is reviewing the Cannabis Act, marking a crucial time for the future of the $4.5 billion cannabis industry. Labstat strongly advocates for the necessity of proper, transparent health information for consumers, a task that requires validated and reliable data that can only come from dedicated research and development. “Given the substantial tax revenues garnered from the industry, both federal and provincial governments should prioritize funding for comprehensive product research and testing,” said Michael Bond, Labstat President. “Our focus is to drive solutions through res...